
|Podcasts|August 19, 2021
Episode 89: Cellicon Valley Outlook
Author(s)Elaine Quilici, Miranda Schmalfuhs
Audrey Greenberg, co-founder and executive managing director of the Center for Breakthrough Medicines and Discovery Labs, discusses how cell and gene therapy has turned Philadelphia into Cellicon Valley, and how her organization is playing a role in that growth even beyond the city’s borders.
Advertisement
Audrey Greenberg, co-founder and executive managing director of the Center for Breakthrough Medicines and Discovery Labs, discusses how cell and gene therapy has turned Philadelphia into Cellicon Valley, and how her organization is playing a role in that growth even beyond the city’s borders.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
How Exposed is The U.S. Pharmaceutical Supply Chain to China’s Updated Export Control Regulations?
2
Bristol Myers Squibb Expands Collaboration with Nvidia to Build AI Factory
3
Staying Ahead of Viral Evolution: Q&A with Robert Allen, Ph.D
4
Pharmaceutical Executive Daily: Bristol Myers Squibb Expands Partnership with Nvidia
5

